Analysis reveals collaborative innovation enhances performance under foreign competition, suggesting optimal R&D strategies.
In this paper, we first establish a series of stylized facts to demonstrate that collaborative innovation, in which firms diversify their R&D activities by outsourcing R&D activities to other research institutes/universities or importing foreign technologies, exhibits better innovation performance than self‐innovation. When facing more intensified foreign competition, only firms whose R&D capacity belongs to the upper‐middle percentiles diversify their R&D activities, whereas other firms' innovation diversification remains unaffected. We next develop a theoretical model to explain the empirical findings. The model incorporates the sequential choices of heterogeneous firms regarding innovation mode, R&D investment, and optimal markup under foreign competition. In equilibrium, a subset of firms switches from self‐innovation to diversified innovation to improve innovation performance and escape competition. After structurally estimating the model's parameters, we conduct a battery of counterfactual experiments, such as varying the degree of foreign‐technology dependence, to identify the optimal path for enhancing Chinese firms' innovation performance amid rising uncertainty in international markets.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: